U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Malignant Lung and Pleural Neoplasm

MedGen UID:
310977
•Concept ID:
C1708889
•
Neoplastic Process

Definition

A primary or metastatic malignant neoplasm that affects the lung and pleura. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVMalignant Lung and Pleural Neoplasm

Professional guidelines

PubMed

Malignant Pleural Effusion: Presentation, Diagnosis, and Management.
Gayen S
Am J Med 2022 Oct;135(10):1188-1192. Epub 2022 May 14 doi: 10.1016/j.amjmed.2022.04.017. PMID: 35576996
Malignant Pleural Effusion: Diagnosis and Management.
Ferreiro L, Suárez-Antelo J, Álvarez-Dobaño JM, Toubes ME, Riveiro V, Valdés L
Can Respir J 2020;2020:2950751. Epub 2020 Sep 23 doi: 10.1155/2020/2950751. PMID: 33273991Free PMC Article
Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment.
Jany B, Welte T
Dtsch Arztebl Int 2019 May 24;116(21):377-386. doi: 10.3238/arztebl.2019.0377. PMID: 31315808Free PMC Article

Recent clinical studies

Etiology

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆).
Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson AG, Nowak AK, Opitz I, Scherpereel A, Reck M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Ann Oncol 2022 Feb;33(2):129-142. Epub 2021 Nov 30 doi: 10.1016/j.annonc.2021.11.005. PMID: 34861373
What's new in mesothelioma.
Ascoli V, Murer B, Nottegar A, Luchini C, Carella R, Calabrese F, Lunardi F, Cozzi I, Righi L
Pathologica 2018 Mar;110(1):12-28. PMID: 30259910
A catalogue of treatment and technologies for malignant pleural mesothelioma.
Schunselaar LM, Quispel-Janssen JM, Neefjes JJ, Baas P
Expert Rev Anticancer Ther 2016;16(4):455-63. doi: 10.1586/14737140.2016.1162100. PMID: 26943000
Biomarkers and prognostic factors for malignant pleural mesothelioma.
Vigneri P, Martorana F, Manzella L, Stella S
Future Oncol 2015;11(24 Suppl):29-33. doi: 10.2217/fon.15.317. PMID: 26638920
Rare pleural tumors.
Erb CT, Johnson KM, Kim AW
Clin Chest Med 2013 Mar;34(1):113-36. doi: 10.1016/j.ccm.2012.12.001. PMID: 23411062

Diagnosis

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆).
Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson AG, Nowak AK, Opitz I, Scherpereel A, Reck M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Ann Oncol 2022 Feb;33(2):129-142. Epub 2021 Nov 30 doi: 10.1016/j.annonc.2021.11.005. PMID: 34861373
Malignant Mesothelioma: Has Anything Changed?
Kim RY, Sterman DH, Haas AR
Semin Respir Crit Care Med 2019 Jun;40(3):347-360. Epub 2019 Sep 16 doi: 10.1055/s-0039-1693406. PMID: 31525810
What's new in mesothelioma.
Ascoli V, Murer B, Nottegar A, Luchini C, Carella R, Calabrese F, Lunardi F, Cozzi I, Righi L
Pathologica 2018 Mar;110(1):12-28. PMID: 30259910
Pleural neoplastic pathology.
Karpathiou G, Stefanou D, Froudarakis ME
Respir Med 2015 Aug;109(8):931-43. Epub 2015 May 21 doi: 10.1016/j.rmed.2015.05.014. PMID: 26048082
Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F
Arch Bronconeumol 2015 Apr;51(4):177-84. Epub 2014 Jul 22 doi: 10.1016/j.arbres.2014.06.005. PMID: 25059587

Therapy

Immunotherapy approaches for malignant pleural mesothelioma.
Fennell DA, Dulloo S, Harber J
Nat Rev Clin Oncol 2022 Sep;19(9):573-584. Epub 2022 Jul 1 doi: 10.1038/s41571-022-00649-7. PMID: 35778611
Mesothelioma and Radical Surgery 2 (MARS 2): protocol for a multicentre randomised trial comparing (extended) pleurectomy decortication versus no (extended) pleurectomy decortication for patients with malignant pleural mesothelioma.
Lim E, Darlison L, Edwards J, Elliott D, Fennell DA, Popat S, Rintoul RC, Waller D, Ali C, Bille A, Fuller L, Ionescu A, Keni M, Kirk A, Koh P, Lau K, Mansy T, Maskell NA, Milton R, Muthukumar D, Pope T, Roy A, Shah R, Shamash J, Tasigiannopoulos Z, Taylor P, Treece S, Ashton K, Harris R, Joyce K, Warnes B, Mills N, Stokes EA, Rogers C; MARS 2 Trialists
BMJ Open 2020 Sep 1;10(9):e038892. doi: 10.1136/bmjopen-2020-038892. PMID: 32873681Free PMC Article
Malignant Mesothelioma: Has Anything Changed?
Kim RY, Sterman DH, Haas AR
Semin Respir Crit Care Med 2019 Jun;40(3):347-360. Epub 2019 Sep 16 doi: 10.1055/s-0039-1693406. PMID: 31525810
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
Scherpereel A, Mazieres J, Greillier L, Lantuejoul S, Dô P, Bylicki O, Monnet I, Corre R, Audigier-Valette C, Locatelli-Sanchez M, Molinier O, Guisier F, Urban T, Ligeza-Poisson C, Planchard D, Amour E, Morin F, Moro-Sibilot D, Zalcman G; French Cooperative Thoracic Intergroup
Lancet Oncol 2019 Feb;20(2):239-253. Epub 2019 Jan 16 doi: 10.1016/S1470-2045(18)30765-4. PMID: 30660609
Malignant pleural mesothelioma.
Raja S, Murthy SC, Mason DP
Curr Oncol Rep 2011 Aug;13(4):259-64. doi: 10.1007/s11912-011-0177-9. PMID: 21573909

Prognosis

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆).
Popat S, Baas P, Faivre-Finn C, Girard N, Nicholson AG, Nowak AK, Opitz I, Scherpereel A, Reck M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Ann Oncol 2022 Feb;33(2):129-142. Epub 2021 Nov 30 doi: 10.1016/j.annonc.2021.11.005. PMID: 34861373
DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma.
González IA, Stewart DR, Schultz KAP, Field AP, Hill DA, Dehner LP
Mod Pathol 2022 Jan;35(1):4-22. Epub 2021 Oct 1 doi: 10.1038/s41379-021-00905-8. PMID: 34599283Free PMC Article
What's new in mesothelioma.
Ascoli V, Murer B, Nottegar A, Luchini C, Carella R, Calabrese F, Lunardi F, Cozzi I, Righi L
Pathologica 2018 Mar;110(1):12-28. PMID: 30259910
Pleural neoplastic pathology.
Karpathiou G, Stefanou D, Froudarakis ME
Respir Med 2015 Aug;109(8):931-43. Epub 2015 May 21 doi: 10.1016/j.rmed.2015.05.014. PMID: 26048082
Pleural malignancies.
Friedberg JS, Cengel KA
Semin Radiat Oncol 2010 Jul;20(3):208-14. doi: 10.1016/j.semradonc.2010.01.009. PMID: 20685584

Clinical prediction guides

Immunotherapy approaches for malignant pleural mesothelioma.
Fennell DA, Dulloo S, Harber J
Nat Rev Clin Oncol 2022 Sep;19(9):573-584. Epub 2022 Jul 1 doi: 10.1038/s41571-022-00649-7. PMID: 35778611
Malignant Pleural Effusion and Its Current Management: A Review.
Skok K, Hladnik G, Grm A, Crnjac A
Medicina (Kaunas) 2019 Aug 15;55(8) doi: 10.3390/medicina55080490. PMID: 31443309Free PMC Article
What's new in mesothelioma.
Ascoli V, Murer B, Nottegar A, Luchini C, Carella R, Calabrese F, Lunardi F, Cozzi I, Righi L
Pathologica 2018 Mar;110(1):12-28. PMID: 30259910
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, Maskell NA, Psallidas I
Eur Respir Rev 2016 Dec;25(142):472-486. doi: 10.1183/16000617.0063-2016. PMID: 27903668Free PMC Article
Malignant pleural effusions because of lung cancer.
Porcel JM
Curr Opin Pulm Med 2016 Jul;22(4):356-61. doi: 10.1097/MCP.0000000000000264. PMID: 27055072

Recent systematic reviews

Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis.
Martinez-Zayas G, Molina S, Ost DE
Eur Respir Rev 2022 Dec 31;31(166) Epub 2022 Dec 21 doi: 10.1183/16000617.0053-2022. PMID: 36543349Free PMC Article
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D, Galateau-Salle F, Greillier L, Hoda MA, Klepetko W, Lacourt A, McElnay P, Maskell NA, Mutti L, Pairon JC, Van Schil P, van Meerbeeck JP, Waller D, Weder W, Cardillo G, Putora PM
Eur Respir J 2020 Jun;55(6) Epub 2020 Jun 11 doi: 10.1183/13993003.00953-2019. PMID: 32451346
Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO
Cochrane Database Syst Rev 2020 Apr 21;4(4):CD010529. doi: 10.1002/14651858.CD010529.pub3. PMID: 32315458Free PMC Article
Management of Malignant Pleural Effusions. An Official ATS/STS/STR Clinical Practice Guideline.
Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK, Henry T, Iyer NP, Lee YCG, Lewis SZ, Maskell NA, Rahman NM, Sterman DH, Wahidi MM, Balekian AA
Am J Respir Crit Care Med 2018 Oct 1;198(7):839-849. doi: 10.1164/rccm.201807-1415ST. PMID: 30272503
Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis.
Ren R, Yin P, Zhang Y, Zhou J, Zhou Y, Xu R, Lin H, Huang C
Oncotarget 2016 Dec 20;7(51):84851-84859. doi: 10.18632/oncotarget.12707. PMID: 27769044Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...